Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications

Coronavirus disease 2019 (COVID-19) induces a hypercoagulatory state that frequently leads to thromboembolic complications. Whereas anticoagulation is associated with reduced mortality, the role of antiplatelet therapy in COVID-19 is less clear. We retrospectively analyzed the effect of anticoagulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schrottmaier, Waltraud C., Pirabe, Anita, Pereyra, David, Heber, Stefan, Hackl, Hubert, Schmuckenschlager, Anna, Brunnthaler, Laura, Santol, Jonas, Kammerer, Kerstin, Oosterlee, Justin, Pawelka, Erich, Treiber, Sonja M., Khan, Abdullah O., Pugh, Matthew, Traugott, Marianna T., Schörgenhofer, Christian, Seitz, Tamara, Karolyi, Mario, Jilma, Bernd, Rayes, Julie, Zoufaly, Alexander, Assinger, Alice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818754/
https://www.ncbi.nlm.nih.gov/pubmed/35141292
http://dx.doi.org/10.3389/fcvm.2021.802566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818754/
https://www.ncbi.nlm.nih.gov/pubmed/35141292
http://dx.doi.org/10.3389/fcvm.2021.802566

Ejemplares similares